3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Metabolic Syndrome
1
Lymphoma, Non-Hodgkin
1
Heart Failure
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Cardiomyopathies
1
Interventions
acalabrutinib
2
Social Determinants of Health
2
Electrocardiography
2
Echocardiography
2
Blood Specimen Collection
2
Aspirin
2
zanubrutinib
1
ribociclib
1
phosphoribosylformylglycinamidine synthetase
1
palbociclib
1
ibrutinib
1
glycidol
1
abemaciclib
1
Vascular Stiffness
1
Testosterone
1
Pulse Wave Analysis
1
Noninvasive Prenatal Testing
1
Magnetic Resonance Spectroscopy
1
Health Services Needs and Demand
1
Gonadotropin-Releasing Hormone
1
Genetic Testing
1
Exercise
1
Eating
1
Diet
1
DNA
1
Chemoradiotherapy
1
Cardiovascular Agents
1
Antineoplastic Agents
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Cardiovascular Diseases
×
Vascular Stiffness
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled